Cancer of unknown primary: how did we get here?

Tony Greco, MD, Tennessee Oncology, Nashville, TN, outlines the current understanding and management of patients with cancer of unknown primary site (CUP). Advancements in adequately diagnosing the occult primary cancer or tissue of origin have occurred with the use of panels of immunocytochemistry and molecular profiling assays. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).